151 related articles for article (PubMed ID: 7624992)
1. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer.
Gao X; Grignon DJ; Chbihi T; Zacharek A; Chen YQ; Sakr W; Porter AT; Crissman JD; Pontes JE; Powell IJ
Urology; 1995 Aug; 46(2):227-37. PubMed ID: 7624992
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
4. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.
Dilly AK; Ekambaram P; Guo Y; Cai Y; Tucker SC; Fridman R; Kandouz M; Honn KV
Int J Cancer; 2013 Oct; 133(8):1784-91. PubMed ID: 23526143
[TBL] [Abstract][Full Text] [Related]
5. Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential.
Timár J; Rásó E; Döme B; Li L; Grignon D; Nie D; Honn KV; Hagmann W
Int J Cancer; 2000 Jul; 87(1):37-43. PubMed ID: 10861450
[TBL] [Abstract][Full Text] [Related]
6. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
[TBL] [Abstract][Full Text] [Related]
7. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
[TBL] [Abstract][Full Text] [Related]
8. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase.
Nie D; Nemeth J; Qiao Y; Zacharek A; Li L; Hanna K; Tang K; Hillman GG; Cher ML; Grignon DJ; Honn KV
Clin Exp Metastasis; 2003; 20(7):657-63. PubMed ID: 14669797
[TBL] [Abstract][Full Text] [Related]
9. Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells.
Kandouz M; Nie D; Pidgeon GP; Krishnamoorthy S; Maddipati KR; Honn KV
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):189-204. PubMed ID: 14518561
[TBL] [Abstract][Full Text] [Related]
10. Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.
Shappell SB; Manning S; Boeglin WE; Guan YF; Roberts RL; Davis L; Olson SJ; Jack GS; Coffey CS; Wheeler TM; Breyer MD; Brash AR
Neoplasia; 2001; 3(4):287-303. PubMed ID: 11571629
[TBL] [Abstract][Full Text] [Related]
11. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
12. Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.
Moretti RM; Montagnani Marelli M; Sala A; Motta M; Limonta P
Int J Cancer; 2004 Oct; 112(1):87-93. PubMed ID: 15305379
[TBL] [Abstract][Full Text] [Related]
13. Requirement for epidermal growth factor receptor tyrosine kinase and for 12-lipoxygenase activity in the expression of 12-lipoxygenase in human epidermoid carcinoma cells.
Hagmann W; Borgers S
Biochem Pharmacol; 1997 Apr; 53(7):937-42. PubMed ID: 9174106
[TBL] [Abstract][Full Text] [Related]
14. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging.
Kelavkar UP; Cohen C; Kamitani H; Eling TE; Badr KF
Carcinogenesis; 2000 Oct; 21(10):1777-87. PubMed ID: 11023533
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.
Pidgeon GP; Tang K; Cai YL; Piasentin E; Honn KV
Cancer Res; 2003 Jul; 63(14):4258-67. PubMed ID: 12874035
[TBL] [Abstract][Full Text] [Related]
16. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.
Shappell SB; Boeglin WE; Olson SJ; Kasper S; Brash AR
Am J Pathol; 1999 Jul; 155(1):235-45. PubMed ID: 10393855
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
18. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
[TBL] [Abstract][Full Text] [Related]
19. Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.
Park HK; Kim H; Kim HG; Cho YM; Jung WY; Han HS; Hwang TS; Kwon GY; Lim SD
J Korean Med Sci; 2015 May; 30(5):533-41. PubMed ID: 25931782
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase.
McCabe NP; Selman SH; Jankun J
Prostate; 2006 May; 66(7):779-87. PubMed ID: 16482570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
